approval
saveOTEZLA (APREMILAST) — FDA approval
community read0 votes
Sponsor: AMGEN INC. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalOTEZLA (APREMILAST) — FDA approvalDec 23, 2025 · 284d ago
- approvalOTEZLA (APREMILAST) — FDA approvalJul 23, 2025 · 437d ago
- approvalOTEZLA (APREMILAST) — FDA approvalApr 25, 2024 · 891d ago
- approvalOTEZLA (APREMILAST) — FDA approvalDec 20, 2021 · 1748d ago
- approvalOTEZLA (APREMILAST) — FDA approvalApr 10, 2020 · 2367d ago
- approvalOTEZLA (APREMILAST) — FDA approvalJul 19, 2019 · 2633d ago
- approvalOTEZLA (APREMILAST) — FDA approvalJun 29, 2017 · 3383d ago
- approvalOTEZLA (APREMILAST) — FDA approvalDec 21, 2015 · 3939d ago
same company · ±60 days · 5
- approvalAMJEVITA: AMJEVITA (ADALIMUMAB-ATTO) — FDA approvalJul 12, 2023
- approvalAMJEVITA: AMJEVITA (ADALIMUMAB-ATTO) — FDA approvalAug 14, 2023
- approvalblinatumomab: BLINCYTO (BLINATUMOMAB) — FDA approvalJun 20, 2023
- approvalblinatumomab: BLINCYTO (BLINATUMOMAB) — FDA approvalJun 20, 2023
- approvalENBREL (ETANERCEPT) — FDA approvalJun 9, 2023
🐶 often sniffed alongside
top 8- drugOTEZLA31 co-mentions · 17 sources
- tagApproval28 co-mentions · 14 sources
- drugapremilast ER17 co-mentions · 17 sources
- tagSmall Molecule14 co-mentions · 14 sources
- company$AMGNAMGEN INC14 co-mentions · 14 sources
- companyUniversity of Colorado Denver1 co-mentions · 1 sources
- companyUniversity of California Los Angeles1 co-mentions · 1 sources
- companyUniversity of Virginia1 co-mentions · 1 sources
comments(0)
5-min edit window · permanent after that